The anti-cancer effects of BBMD3 in these cells was shown to be associated with the up-regulation of miR-4284 expression and activation of the stress-response JNK signaling pathway, as well as the AP-1 transcriptional factor, a JNK downstream target. Here, JUN is linked to cancer.